KRYSTAL SCHMIEG: Open Payments
NPI 1427774074 · WEST BURLINGTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 11 payments from 8 companies in 2025. Trend: 2023 $448 · 2024 $391 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 1 | $124 |
| GENZYME CORPORATION | 3 | $53 |
| Amgen Inc. | 1 | $49 |
| Insulet Corporation | 1 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: Ohtuvayre, DUPIXENT, KRYSTEXXA, OMNIPOD, BREZTRI, NUCALA.
Industry payments across IA — which companies pay providers there.
